Last Updated: August 8, 2026

Details for Patent: 8,292,129

Name: Drug Patent Intelligence for US Patent 8292129
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,292,129 protect, and when does it expire?

Patent 8,292,129 protects RESTASIS MULTIDOSE and is included in one NDA.

This patent has four patent family members in three countries.

Summary for Patent: 8,292,129

Title:	Dispensing device
Abstract:	A dispensing device for liquid media having a housing, a medium reservoir, an outlet opening for dispensing the medium and an inlet opening for intake of air for the purpose of volume equalization in the medium reservoir, wherein a cap is provided that is fittable onto the housing and protects the outlet opening when in the fitted state. The cap closes the inlet opening in gas-tight manner from an environment on the one hand and from the outlet opening on the other hand.
Inventor(s):	Peter Stadelhofer, Juergen Greiner-Perth
Assignee:	Aptar Radolfzell GmbH
Application Number:	US12/657,081
Patent Claim Types: see list of patent claims	Device;

Drugs Protected by US Patent 8,292,129

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Abbvie	RESTASIS MULTIDOSE	cyclosporine	EMULSION;OPHTHALMIC	050790-002	Oct 27, 2016		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y		Y		⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,292,129

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2009 006 430	Jan 23, 2009

International Family Members for US Patent 8,292,129

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Germany	102009006430	⤷ Start Trial
European Patent Office	2210674	⤷ Start Trial
Japan	2010168119	⤷ Start Trial
Japan	5390420	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.